A new genetic study has found evidence that celiac disease may increase the risk of pulmonary arterial hypertension, a serious condition affecting blood vessels in the lungs. Researchers used large public genetic databases to explore whether celiac disease plays a causal role in this vascular disease, rather than simply appearing alongside it by chance.

What Is Pulmonary Arterial Hypertension and Why Should People With Celiac Disease Care?

Pulmonary arterial hypertension (PAH) is a progressive condition in which pressure rises inside the arteries that carry blood from the heart to the lungs. Over time, the walls of these blood vessels can become narrowed, thickened, or stiff, making it harder for blood to move through the lungs. This forces the right side of the heart to work harder than normal.

The symptoms of PAH can be vague and easy to overlook at first, which is why early recognition matters. Common signs include shortness of breath, fatigue, chest discomfort, dizziness, fainting, swelling in the legs, and reduced ability to exercise. In advanced stages, PAH can become life-threatening.

Doctors already know that PAH is linked to other autoimmune diseases, especially systemic lupus erythematosus, systemic sclerosis, and Sjögren's syndrome. Since celiac disease is also an immune-driven condition, researchers wanted to investigate whether a genetic and biological connection might exist between celiac disease and PAH.

How Did Researchers Study This Connection?

The researchers used a genetic research method that examines whether inherited genetic patterns associated with one condition are also linked to the risk of another condition. This approach is valuable because genes are assigned before birth and are not usually affected by lifestyle, disease symptoms, or later health changes. This helps reduce confusion that can occur in ordinary observational studies, where it can be difficult to determine whether one condition caused another or whether both were influenced by a third factor.

The team analyzed genetic information from large public databases, focusing primarily on people of European ancestry. They tested the relationship in more than one group and then combined the results to see whether the finding remained consistent. Importantly, they also adjusted for obesity and smoking, since both can influence vascular health and could otherwise complicate the results.

The study found genetic evidence that celiac disease was associated with an increased risk of PAH. The relationship was seen in both the discovery group and the replication group, and the combined analysis also supported the connection. Notably, the association remained after researchers adjusted for obesity and smoking, suggesting that the possible link between celiac disease and PAH may not simply be explained by those common risk factors.

What Are the Possible Biological Pathways Connecting Celiac Disease to Lung Problems?

Researchers identified several potential mechanisms that could explain how celiac disease might increase PAH risk. These pathways involve immune system activity, inflammation, and nutrient absorption, all of which can extend beyond the digestive system.

• Inflammation in blood vessel lining: When the immune system remains activated, it can influence the cells that line blood vessels, including those in the lungs. This may contribute to vessel narrowing, remodeling, and increased pressure in the pulmonary arteries.
• Nutrient deficiencies: People with celiac disease can develop deficiencies in iron, folate, and fat-soluble vitamins, especially before diagnosis or when intestinal healing is incomplete. These nutrient deficiencies may affect blood vessel function, oxygen handling, inflammation, and repair processes.
• Changes in the gut barrier and microbiome: If intestinal inflammation increases gut permeability, immune-triggering substances may enter the bloodstream more easily. This could contribute to wider immune activation and vascular stress, though this idea is still developing and needs more research.

The researchers also examined whether other autoimmune diseases might help explain part of the pathway between celiac disease and PAH. Among the autoimmune diseases examined, systemic lupus erythematosus appeared to partially mediate the relationship. In practical terms, this means that part of the increased risk may involve shared immune pathways that overlap with lupus-like immune activity, although this does not mean that everyone with celiac disease has or will develop lupus.

What Should People With Celiac Disease Do About These Findings?

It is important to emphasize that this study provides genetic evidence supporting a possible causal relationship, but it does not prove that every person with celiac disease has a high risk of PAH. The increase in risk appears meaningful from a research perspective, but PAH remains a relatively uncommon condition. Additionally, the study focused mainly on people of European ancestry, so the results may not apply equally to all populations.

The study also does not suggest that people with celiac disease should panic or assume that breathing symptoms are caused by PAH. Many far more common conditions can cause shortness of breath or fatigue, including anemia, asthma, infections, deconditioning, thyroid disease, and anxiety. However, persistent or unexplained symptoms should be discussed with a healthcare provider.

Steps to Monitor Your Health if You Have Celiac Disease

• Track respiratory symptoms: Pay attention to unexplained shortness of breath, chest discomfort, fainting, unusual fatigue, swelling in the legs, or reduced exercise tolerance. These symptoms are worth discussing with a doctor, particularly if they are persistent or worsening.
• Maintain strict adherence to a gluten-free diet: The gluten-free diet remains the foundation of celiac disease treatment. Strict adherence helps control immune inflammation and may eventually prove important for reducing broader health risks beyond the digestive system.
• Ensure timely diagnosis and follow-up care: Early diagnosis and consistent monitoring for associated autoimmune conditions are important. If immune inflammation is part of the pathway connecting celiac disease to vascular problems, then better control of celiac disease and related autoimmune activity may help reduce broader health risks.
• Discuss screening with your healthcare provider: If you have celiac disease and experience any of the symptoms associated with PAH, bring them up during your next appointment. Your doctor can determine whether additional evaluation is warranted based on your individual health profile.

Why This Research Matters for Understanding Celiac Disease

For people with celiac disease, this study reinforces an important concept: celiac disease is a whole-body autoimmune condition, not just a digestive disorder. While the gluten-free diet is essential, long-term care should also pay attention to symptoms and health concerns outside the gut.

This research adds to a growing body of evidence that celiac disease can have effects beyond the small intestine. The findings support the importance of comprehensive, long-term monitoring and the recognition that autoimmune conditions often have systemic effects. More clinical research is needed to determine which patients with celiac disease may be at greatest risk for PAH, whether risk changes after diagnosis and treatment, and whether a strict gluten-free diet lowers this risk over time.